Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction
{{output}}
Background: Zalunfiban is a glycoprotein IIb/IIIa (integrin αIIbβ3) inhibitor designed for subcutaneous administration on first medical contact with patients with suspected ST-segment elevation myocardial infarction (STEMI). ... ...
